A Clinical Comparison of Two Inverse Intense Modulated Radiotherapy Treatment Planning Systems

ZHANG Ying,XIAO Gui-ping,WU hao,HUANG Fei-zeng,BAO Shang-lian

DOI: https://doi.org/10.3969/j.issn.1005-202x.2012.05.001

2012-01-01

Abstract:Objective: To evaluate the inverse optimization TPS(HW-3D TPS) developed by Beijing Healthware Technological Inc. the Research Center for Tumor Diagnosis and Therapeutical Physics,Peking University,to see if this TPS reached the level for commercial application.Methods: Using our own HW-3D TPS and clinical real cases to optimize the dose distribution obtain the dose distribution according the prescription,to see if it meets the physician requirement on the treatment target and its surrounding organs at risk.This results were compared with the commercialized TPS software Varian EclipseA10 with the same patient prescriptions for a comprehensive evaluation.Results: 11 pathological cases were studied and compared,which had the typical significance in human body.We got the following results:All the dos distributions were satisfied with the prescription given by clinicians.95% of the PTV volume could reach 95% of prescription dose;PTV STD check,which should be less than 5%,that means that the PTV 95% of the volume has achieved 95% of the prescribed dose(the result meet the national standards);Comprehensive comparison of the two TPS system with the PTV STD value,the STD of Varian Eclipse A10 PTV was 2.8% in average;the PTV STD of HW-3D TPS was 2.2% in average,which achieved the comparability within the permissible uncertainty range.Conclusions: HW-3D TPS has good treatment capability for clinical cases in inverse optimization process,which is also comparable with the commercial TPS system.